Niva Bupa Health

30
Sell
  • Market Cap: Small Cap
  • Industry: Insurance
  • ISIN: INE995S01015
  • NSEID: NIVABUPA
  • BSEID: 544286
INR
73.71
-0.72 (-0.97%)
BSENSE

Dec 05

BSE+NSE Vol: 5.07 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 26.90% vs 32.72% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 103.86% vs 6.92% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 19.62% vs 17.92% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 160.87% vs 552.66% in Mar 2024

Compare Profit and Loss Results of Niva Bupa Health
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
5,324.00
41,066.00
-35,742.00
-87.04%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
5,324.00
41,066.00
-35,742.00
-87.04%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
663.00
2,612.00
-1,949.00
-74.62%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
0.00
0.00
0.00
0%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
-62.00
-91.00
29.00
31.87%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
5,163.00
41,410.00
-36,247.00
-87.53%
Operating Profit (PBDIT) excl Other Income
160.00
-344.00
504.00
146.51%
Other Income
205.00
2,388.00
-2,183.00
-91.42%
Operating Profit (PBDIT)
366.00
2,044.00
-1,678.00
-82.09%
Interest
127.00
199.00
-72.00
-36.18%
Profit before Depriciation and Tax
238.00
1,845.00
-1,607.00
-87.10%
Depreciation
24.00
48.00
-24.00
-50.00%
Profit Before Taxation & Exceptional Items
214.00
1,796.00
-1,582.00
-88.08%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
213.00
1,034.00
-821.00
-79.40%
Provision for Tax
0.00
46.00
-46.00
-100.00%
Profit After Tax
213.00
988.00
-775.00
-78.44%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
213.00
988.00
-775.00
-78.44%
Appropriations
213.00
988.00
-775.00
-78.44%
Equity Dividend (%)
0%
36%
-36.00
Earnings Per Share
1.22
6
-4.78
-79.67%
Profit And Loss - Net Sales
Net Sales 5,324.26 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 26.90% vs 32.72% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 160.64 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 103.86% vs 6.92% in Mar 2024

Profit And Loss - Interest
Interest 127.32 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 19.62% vs 17.92% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 213.52 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 160.87% vs 552.66% in Mar 2024